HomeCGEM • NASDAQ
add
Cullinan Therapeutics Inc
Previous close
$8.74
Day range
$7.59 - $8.66
Year range
$5.68 - $17.77
Market cap
464.03M USD
Avg Volume
1.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 75.80M | 51.51% |
Net income | -70.06M | -66.69% |
Net profit margin | — | — |
Earnings per share | -1.07 | -42.67% |
EBITDA | -75.72M | -51.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 265.48M | -59.93% |
Total assets | 520.33M | -23.62% |
Total liabilities | 28.18M | 12.75% |
Total equity | 492.15M | — |
Shares outstanding | 59.07M | — |
Price to book | 1.05 | — |
Return on assets | -34.45% | — |
Return on capital | -36.19% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -70.06M | -66.69% |
Cash from operations | -57.61M | -58.74% |
Cash from investing | 53.40M | 128.85% |
Cash from financing | 373.00K | -99.86% |
Net change in cash | -3.84M | -109.40% |
Free cash flow | -33.23M | -53.95% |
About
Founded
2016
Website
Employees
111
